This white paper examines how high-quality, culturally appropriate translation improves patient engagement, recruitment, retention, and data integrity in global clinical trials. It highlights the risks of literal translation errors and emphasizes the importance of native-speaking subject matter experts and fit-for-purpose technology. Case examples demonstrate how culturally adapted materials can significantly improve enrollment and adherence. The report positions language solutions as a strategic enabler of regulatory compliance, health equity, and operational efficiency in increasingly globalized and complex trial environments.

Join for free to read